Literature DB >> 2503149

Who should have their cholesterol concentration measured? What experts in the United Kingdom suggest.

D Leitch1.   

Abstract

General practitioners are being encouraged to participate in preventive care, including preventing coronary heart disease. Now that they can measure cholesterol concentrations in their surgeries they need to decide which patients should be screened. Several reports on measuring cholesterol concentrations in the United Kingdom were reviewed to see if experts agreed about who ought to be screened. The results showed that currently no national consensus exists, making it difficult for general practitioners to plan policies for their patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503149      PMCID: PMC1836896          DOI: 10.1136/bmj.298.6688.1615

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  8 in total

1.  Blood cholesterol: is population screening warranted in the UK?

Authors:  W C Smith; M B Kenicer; A M Davis; A E Evans; J Yarnell
Journal:  Lancet       Date:  1989-02-18       Impact factor: 79.321

Review 2.  Coronary heart disease prevention: a general practice challenge.

Authors:  G Fowler
Journal:  J R Coll Gen Pract       Date:  1988-09

3.  Quality of plasma cholesterol measurements in primary care.

Authors:  P M Broughton; D G Bullock; R Cramb
Journal:  BMJ       Date:  1989-02-04

4.  Prevention of cardiovascular disease in general practice: a proposed model.

Authors:  E E Anggard; J M Land; C J Lenihan; C J Packard; M J Percy; L D Ritchie; J Shepherd
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-19

5.  Reduction of blood cholesterol levels in the population: can it be done?

Authors:  J T Hart
Journal:  J R Coll Gen Pract       Date:  1986-12

6.  High cholesterol levels: is mass screening the best option?

Authors:  S Kinlay
Journal:  Med J Aust       Date:  1988-06-20       Impact factor: 7.738

7.  Fluctuating serum cholesterol: implications for coronary prevention.

Authors:  B H Natelson; W N Tapp; A Munsif; W Burns
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

8.  Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association.

Authors:  J Shepherd; D J Betteridge; P Durrington; M Laker; B Lewis; J Mann; J P Miller; J P Reckless; G R Thompson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14
  8 in total
  7 in total

Review 1.  Indications for lipid-lowering drugs.

Authors:  J Davignon
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Set menus and clinical freedom.

Authors:  T C O'Dowd; A D Wilson
Journal:  BMJ       Date:  1991-08-24

3.  Follow-up study of participants in an extensive health examination programme at a Swedish industry.

Authors:  G Rose; C Bengtsson
Journal:  Klin Wochenschr       Date:  1990-12-30

4.  Pharmacoeconomic evaluation of risk factors for cardiovascular disease: an epidemiological perspective.

Authors:  A E Fletcher; C J Bulpitt
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

5.  Screening for hyperlipidaemia: general practitioners' views.

Authors:  S Whitehead; P Conridge; H Fender
Journal:  BMJ       Date:  1989-08-26

6.  Cholesterol screening programmes: how much potential benefit?

Authors:  K T Khaw; G Rose
Journal:  BMJ       Date:  1989-09-02

7.  Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.

Authors: 
Journal:  BMJ       Date:  1991-10-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.